was added to your cart!
Checkout

General

Bringing the Lab to You

Key takeaways
Copy
  • Mobile phlebotomy removes access barriers by bringing clinical-grade blood collection directly to patients, participants, and employees.
  • Improved access drives better outcomes, including higher completion rates, faster turnaround times, and stronger data integrity.
  • Nationwide mobile diagnostics support decentralized care, from clinical trials to remote care and employer programs.
  • Healthcare on your terms

    At imaware, we believe access to diagnostics shouldn’t depend on where you live, how mobile you are, or whether you can get to a lab.

    That’s why we’re proud to announce the launch of imaware’s nationwide Mobile Phlebotomy Network, designed to bring clinical-grade blood collection directly to patients wherever they are.

    The Last Mile of Healthcare

    In logistics, the toughest part of any delivery isn’t the highway; it’s the last mile.
    The final stretch between “almost there” and “arrived.”
    It’s where timing fails, participation drops, and friction grows.

    Healthcare faces the same challenge.

    For many of imaware’s partners (digital health companies, decentralized clinical trial sponsors, employer wellness programs, and remote care platforms), the hardest part of diagnostics is often simply getting patients to a draw site. Even when the program itself is innovative and well-designed, the logistics of in-person blood collection create delays, no-shows, and lost data.

    That last mile becomes the bottleneck.

    Why This Matters

    For years, access to diagnostic testing has been limited by geography, mobility, time, or transportation. Mobile phlebotomy removes these barriers entirely, especially for remote-first programs, decentralized trials, and distributed employers.

    The result is:

    • Higher completion rates
    • Faster turnaround times
    • Better patient experiences
    • Improved compliance and data integrity
    • Reduced burden on clinical operations teams

    All without compromising clinical quality.

    A New Standard for Decentralized Care

    This capability supports modern healthcare delivery models such as:

    • Decentralized and hybrid clinical trials
    • Corporate wellness and population health programs
    • At-home care and chronic condition monitoring
    • Telehealth and virtual-first care providers

    Every draw is performed by a trained professional following the same standards as traditional labs, now delivered with greater flexibility and accessibility.

    How It Works

    1. Participants receive a test order via imaware or your existing company platform
    2. They schedule a convenient mobile appointment through the imaware platform
    3. A licensed phlebotomist (via TravaLab) arrives at their home, office, or preferred location
    4. Samples are collected and transported to CLIA-certified labs
    5. Results are processed and shared digitally through the platform of choice

    Lab-quality diagnostics. Made mobile, modern, and patient-centric.

    Powering Access, Equity, and Better Outcomes

    Mobile phlebotomy allows partners to reach patients who are typically underserved or unable to access traditional diagnostic pathways. It expands program reach, reduces participant drop-off, and supports inclusive study design.

    This capability also integrates seamlessly with imaware’s broader ecosystem, including at-home devices like Tasso and future biomarkers like suPAR. This creates a unified, patient-centered diagnostic experience.

    Get Started

    Whether you’re running a clinical study, managing a distributed workforce, or delivering remote care, imaware’s Mobile Phlebotomy Network is ready to support you.

    Partner with imaware to enable mobile diagnostics in your programs.
    sales@imaware.health

    Updated on
    January 29, 2026
    Shop now

    REFERENCES

    TRUSTED BY FORWARD-THINKING HEALTH ORGANIZATIONS